Rose Meltzer

While the federal government would still pick up most of the tab, shifting the burden of high-cost patients would reduce out-of-pocket costs for beneficiaries, says the American Action Forum.

The committee has spent the last year working to understand what “regulatory burden” means to providers. Now, it wants to act to help them.

PBMs collected $224.8 million from taxpayers last year through the model, including more than $208 million on generic drugs. The state will no longer permit it, forcing PBMs to restructure their contracts.

With the sale of KMG, Humana is no longer involved in the commercial long-term care industry. But the net loss was minimized by a healthy tax break.

Some suspect the Senate Judiciary Committee, which he chairs, will hold hearings about the pending CVS-Aetna and Cigna-Express Scripts deals in the near future.

Prominent investor Carl Icahn justified his retreat from opposing the deal by pointing to recommendations from Institutional Shareholder Services and Glass Lewis.

Google has 14 years on Oscar, but both companies focus on reaching consumers in a technologically advanced, disruptive way.

The Justice Department selected the cities for the Strike Force’s newest division due to the prominence of fraud, including illegal opioid distribution, in the region.

Although some ACOs may leave the program, the goal should be quality over quantity, says former Obama health IT official Farzad Mostashari. But NAACOs says Track 1 ACOs need more time to get their bearings.